EUVIMEDEUVIMED entdecken
Crossref

Defining the Supply of Radiation Oncologists in the United States: An American Society for Radiation Oncology Workforce Report

Michael Weisman, James E Bates, J Isabelle Choi, Pranshu Mohindra, Mudit Chowdhary, Joseph Salama, John Shumway, Andrew Hoover, Zhong Su, Austin J Sim, Chirag Shah

International Journal of Radiation Oncology*Biology*Physics · 2026

DOI: 10.1016/j.ijrobp.2025.09.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Michael Weisman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana. Hauptthemen laut MEDLINE: Radiation Oncologists, Radiation Oncology, Health Workforce. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Novartis, Castle Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An accurate accounting of the current number of practicing radiation oncologists (ROs) is critical to the complete understanding of the workforce dynamics of the field. At present, there is no clear standard on how to assess this, with multiple approaches available. Therefore, the American Society for Radiation Oncology (ASTRO) Workforce Committee reviewed and evaluated multiple approaches in assessing the radiation oncology (RO) workforce supply, including the pros and cons of each approach, while comparing supply estimates in order to define a recommended standard for assessing the RO workforce supply in the United States. Most methods use data from the Centers for Medicare & Medicaid Services (CMS), the American Medical Association, and/or the American Association of Medical Colleges. The ASTRO-sponsored Health Management Associates Workforce Analysis and the American Society of Clinical Oncology (ASCO) approach used multiple data sources, with the ASCO approach including the American Medical Association and CMS data sources. Limitations of each approach are reflective of the data sources used and include an inability to capture all physicians, a lack of routine updating, and/or a lag-time in incorporating entrants to and exits from the workforce. Overall, the assessments across methods demonstrated substantial consistency in results (range of maximum difference, 2.2%-5.0%; mean, 3.0%), with unfiltered data sets consistently reporting higher estimates, likely due to inclusion of ROs not actively practicing. For example, in 2023, filtered estimates ranged from 4935 (ASCO) to 5072 (American Association of Medical Colleges), whereas in 2024, the estimates ranged from 4992 (ASCO) to 5103 (CMS) ROs. Using the ASCO model, we estimate a total of 5100 ROs in 2024, accounting for Veterans Affairs and pediatric-only ROs, understanding this may not account for nonclinical ROs. Additionally, these methods capture "head counts" of the number of ROs, but not their clinical capacity. After reviewing the various approaches, the ASTRO Workforce Committee recommends applying a similar methodology to that in use by ASCO for RO workforce supply assessments. This would allow subsequent workforce models to be compared with a consistent methodology to prevent erroneous conclusions when comparing across methodologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation OncologistsRadiation OncologyHealth WorkforceUnited StatesHumansSocieties, MedicalWorkforceCenters for Medicare and Medicaid Services, U.S.

Autor:innen und Institutionen

  • Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
  • Department of Radiation Oncology, Northside Hospital, Atlanta, Georgia.
  • Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina.

Förderung

  • Novartis
  • Castle Biosciences

Zitieren

APA

Weisman, M., Bates, J. E., Choi, J. I., Mohindra, P., Chowdhary, M., Salama, J., Shumway, J., Hoover, A., Su, Z., Sim, A. J., & Shah, C. (2026). Defining the Supply of Radiation Oncologists in the United States: An American Society for Radiation Oncology Workforce Report. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.09.012

Vancouver

Weisman M, Bates JE, Choi JI, Mohindra P, Chowdhary M, Salama J, et al. Defining the Supply of Radiation Oncologists in the United States: An American Society for Radiation Oncology Workforce Report. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2025.09.012

BibTeX
@article{Weisman2026,
  author = {Weisman, Michael and Bates, James E and Choi, J Isabelle and Mohindra, Pranshu and Chowdhary, Mudit and Salama, Joseph and Shumway, John and Hoover, Andrew and Su, Zhong and Sim, Austin J and Shah, Chirag},
  title = {Defining the Supply of Radiation Oncologists in the United States: An American Society for Radiation Oncology Workforce Report},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  doi = {10.1016/j.ijrobp.2025.09.012}
}
Kostenlos starten →